Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Related content
Volume 16, Number 33, November 2009

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs
pp. 4345-4360(16)
Authors: Kolovou, G. D.; Anagnostopoulou, K. K.; Kostakou, P. M.; Mikhailidis, D. P.

Favourites:Add to Favourites

Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?
pp. 4361-4373(13)
Authors: Fanciullino, R.; Ciccolini, J.

Favourites:Add to Favourites

Chemogenomic Strategies to Expand the Bioactive Chemical Space
pp. 4374-4381(8)
Authors: Jacoby, E.; Mozzarelli, A.

Favourites:Add to Favourites

Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection
pp. 4382-4398(17)
Authors: Morin, D.; Assaly, R.; Paradis, S.; Berdeaux, A.

Favourites:Add to Favourites

The Medicinal Chemistry of Peptides
pp. 4399-4418(20)
Author: Nestor Jr., J. J.

Favourites:Add to Favourites

Protein Cysteine Modifications: (1) Medicinal Chemistry for Proteomics
pp. 4419-4444(26)
Authors: Nagahara, N.; Matsumura, T.; Okamoto, R.; Kajihara, Y.

Favourites:Add to Favourites

Radiolabelled Oligonucleotides for Imaging of Gene Expression with PET
pp. 4445-4461(17)
Authors: Lendvai, G.; Estrada, S.; Bergstrom, M.

Favourites:Add to Favourites

Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide
pp. 4462-4480(19)
Authors: Bourgault, S.; Vaudry, D.; Dejda, A.; Doan, N. D.; Vaudry, H.; Fournier, A.

Favourites:Add to Favourites

The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine
pp. 4481-4489(9)
Authors: Malhotra, B.; Gandelman, K.; Sachse, R.; Wood, N.; Michel, M. C.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more